This is a summary of the European public assessment report (EPAR) for Sprimeo. It explains how the
Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and its recomm ndations on the conditions of use for Sprimeo.
What is Sprimeo used fo ?
the hypertensionMedicinalhas no obvious cause.
- Rasilez - C09XA02
Popisanih lijekova na recept. ATK šifra: "C09XA02"
The medicine can only be obtained with a prescription.
How is Sprim o used?
The recommended dose of Sprimeo is 150 mg once a day. Sprimeo may be taken alone or in combination with other medicines for hypertension, with the exception of ‘angiotensin converting enzyme (ACE) inhibitors’ or ‘angiotensin receptor blockers’ (ARBs) in patients with diabetes, or moderate or severe kidney impairment. It should be taken with a light meal preferably at the same time each day, but grapefruit juice should not be taken together with Sprimeo. The dose of Sprimeo may be increased to 300 mg once a day in patients whose blood pressure is not adequately controlled.
© European Medicines Agency, 2012. Reproduction is authorised provided the source is acknowledged.
How does Sprimeo work?